Financial statements Podkarpackie Centrum Genetyczne Oncogenlab
Balance sheet data of PODKARPACKIE CENTRUM GENETYCZNE ONCOGENLAB
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 1 097 814,72 | 1 564 720,72 | 2 151 814,88 | 1 159 536,73 | 773 389,70 |
| A. Fixed assets | 895 829,41 | 865 174,95 | 755 818,15 | 548 209,03 | 340 599,91 |
| B. Current assets | 201 985,31 | 699 545,77 | 1 395 996,73 | 611 327,70 | 432 789,79 |
| C. Share capital contributions (basic funds) | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - |
| Total liabilities | 1 097 814,72 | 1 564 720,72 | 2 151 814,88 | 1 159 536,73 | 773 389,70 |
| A. Equity | 189 360,62 | 504 179,88 | 1 837 036,16 | 1 065 883,27 | 701 317,87 |
| B. Liabilities and provisions for liabilities | 908 454,10 | 1 060 540,84 | 314 778,72 | 93 653,46 | 72 071,83 |
| I. Long-term liabilities | 902 501,00 | 800 547,05 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 5 953,10 | 259 993,79 | 314 778,72 | 93 653,46 | 72 071,83 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.